Harvard Bioscience, Inc. (HBIO)
8.91
-0.48
(-5.11%)
USD |
NASDAQ |
Nov 16, 16:00
9.25
+0.34
(+3.82%)
After-Hours: 20:00
Harvard Bioscience Enterprise Value : 80.18M for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 80.18M |
| November 13, 2026 | 82.38M |
| November 12, 2026 | 81.58M |
| November 11, 2026 | 83.70M |
| November 10, 2026 | 81.78M |
| November 09, 2026 | 81.00M |
| November 06, 2026 | 77.67M |
| November 05, 2026 | 78.12M |
| November 04, 2026 | 78.81M |
| November 03, 2026 | 79.08M |
| November 02, 2026 | 78.76M |
| October 30, 2026 | 80.14M |
| October 29, 2026 | 79.68M |
| October 28, 2026 | 77.94M |
| October 27, 2026 | 77.62M |
| October 26, 2026 | 77.48M |
| October 23, 2026 | 77.07M |
| October 22, 2026 | 77.57M |
| October 21, 2026 | 78.26M |
| October 20, 2026 | 77.57M |
| October 19, 2026 | 76.43M |
| October 16, 2026 | 76.43M |
| October 15, 2026 | 77.44M |
| October 14, 2026 | 76.71M |
| October 13, 2026 | 77.25M |
| Date | Value |
|---|---|
| October 12, 2026 | 77.12M |
| October 09, 2026 | 77.12M |
| October 08, 2026 | 76.61M |
| October 07, 2026 | 78.31M |
| October 06, 2026 | 78.58M |
| October 05, 2026 | 78.31M |
| October 02, 2026 | 77.57M |
| October 01, 2026 | 76.61M |
| September 30, 2026 | 75.65M |
| September 29, 2026 | 73.94M |
| September 28, 2026 | 74.03M |
| September 25, 2026 | 73.94M |
| September 24, 2026 | 74.21M |
| September 23, 2026 | 74.35M |
| September 22, 2026 | 73.76M |
| September 21, 2026 | 74.12M |
| September 18, 2026 | 73.89M |
| September 17, 2026 | 74.26M |
| September 16, 2026 | 73.98M |
| September 15, 2026 | 74.12M |
| September 14, 2026 | 74.53M |
| September 11, 2026 | 74.26M |
| September 10, 2026 | 74.80M |
| September 09, 2026 | 73.89M |
| September 08, 2026 | 73.89M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.95B |
| Bio-Rad Laboratories, Inc. | 9.385B |
| Bruker Corp. | 10.86B |
| Danaher Corp. | 183.83B |
| Illumina, Inc. | 31.07B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.623M |
| Revenue (Quarterly) | 22.20M |
| Total Expenses (Quarterly) | 24.82M |
| EPS Diluted (Quarterly) | -0.5751 |
| Gross Profit Margin (Quarterly) | 53.80% |
| Profit Margin (Quarterly) | -11.82% |
| Earnings Yield | -29.43% |
| Normalized Earnings Yield | -26.94 |